Macroeconomic headwinds, shifting client preferences, and a deteriorating value proposition are weighing on the global luxury sector. The Business of Fashion and McKinsey outline five strategic imperatives for luxury executives. Source: McKinsey The State of Luxury: How to navigate a slowdown
US consumers’ sentiment and their spending patterns have been out of sync. Here’s how executives can make sense of the mixed signals. Source: McKinsey The ‘value now’ consumer: Making sense of US consumer sentiment and spending
Figma chief product officer Yuhki Yamashita discusses how to leverage connections with customers and communities to promote product-led growth. Source: McKinsey Yuhki Yamashita on ‘user love’ as the fuel for product-led growth
Industry economics are shifting toward non-acute care delivery, healthcare software, data, analytics, and specialty pharmacy segments. Source: McKinsey What to expect in US healthcare in 2025 and beyond
The president of the Council on Foreign Relations explains that companies today are facing the most complex international environment in 80 years. Source: McKinsey Michael Froman on the business implications of geopolitics
Gen AI pilots have shown promise, but for the technology to deliver transformational business value in the life sciences industry, organizations need to rethink how they scale it. Source: McKinsey Scaling gen AI in the life sciences industry
CEOs in pharma, biotech, and medtech are increasingly building patient-centric businesses but are struggling to do so. Avoiding five common roadblocks can help leaders build successful businesses. Source: McKinsey The hidden traps of business building: A guide for life science CEOs
Pharma R&D leaders and their suppliers see transparency as a key to unlocking more effective collaborations and cost efficiencies. Source: McKinsey Building a shared vision for pharma R&D–supplier partnerships
Top-performing pharma companies over the past decade have relied on a short list of critical dealmaking behaviors that drive high external innovation productivity. Source: McKinsey External innovation: Biopharma dealmaking to boost R&D productivity
Three lighthouse use cases serve as a blueprint for AI’s potential to improve the speed, efficiency, and quality of clinical trials. Source: McKinsey Unlocking peak operational performance in clinical development with artificial intelligence